NGFR Antibodies

Santa Cruz Biotechnology features a diverse variety of NGFR monoclonal antibodies for investigating nerve growth factor receptor (NGFR) in various biological processes. NGFR monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). NGFR, also known as p75NTR, is a critical receptor involved in neuronal survival, differentiation, and apoptosis. NGFR influences neurotrophic signaling pathways and contributes to the development and maintenance of neurons. Research focused on NGFR advances the understanding of mechanisms underlying neurodegenerative diseases. NGFR studies help identify potential therapeutic targets for neurological conditions. Investigating NGFR signaling pathways reveals important insights into neural development and regeneration. Understanding NGFR function aids in developing targeted treatments for neurological disorders. Santa Cruz Biotechnology monoclonal antibodies for NGFR research support scientists worldwide in advancing neuroscience discoveries and therapeutic developments.